|
2026-06-09 |
2026-06-08 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
70 014
+16.9%
310,94
240 310 $US
|
70 014
+16.9%
|
310,94
|
240 310 $US
|
|
|
2026-06-09 |
2026-06-08 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
95 759
-46.7%
43,56
2 700 464 $US
|
95 759
-46.7%
|
43,56
|
2 700 464 $US
|
|
|
2026-06-08 |
2026-06-08 |
PrS
Vente proposée
|
Officer
Dirigeant
|
61 820
400,32
3 953 970 $US
|
61 820
|
400,32
|
3 953 970 $US
|
|
|
2026-02-26 |
2026-02-19 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
385
-1.2%
97,82
37 661 $US
|
385
-1.2%
|
97,82
|
37 661 $US
|
|
|
2026-02-26 |
2026-02-19 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
668
-2.0%
97,83
65 347 $US
|
668
-2.0%
|
97,83
|
65 347 $US
|
|
|
2026-02-26 |
2026-02-19 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
19 255
-36.3%
97,77
1 882 561 $US
|
19 255
-36.3%
|
97,77
|
1 882 561 $US
|
|
|
2026-02-26 |
2026-02-19 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
30 568
-36.5%
97,66
2 985 375 $US
|
30 568
-36.5%
|
97,66
|
2 985 375 $US
|
|
|
2026-02-26 |
2026-02-19 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
1 648
-1.9%
97,86
161 273 $US
|
1 648
-1.9%
|
97,86
|
161 273 $US
|
|
|
2026-02-19 |
2026-02-19 |
PrS
Vente proposée
|
Officer
Dirigeant
|
52 524
97,71
5 132 217 $US
|
52 524
|
97,71
|
5 132 217 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
500
-1.1%
102,08
51 040 $US
|
500
-1.1%
|
102,08
|
51 040 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
325
-0.7%
102,06
33 170 $US
|
325
-0.7%
|
102,06
|
33 170 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
227
-0.5%
102,05
23 165 $US
|
227
-0.5%
|
102,05
|
23 165 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
825
-1.7%
102,04
84 183 $US
|
825
-1.7%
|
102,04
|
84 183 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
1 995
-4.0%
102,03
203 550 $US
|
1 995
-4.0%
|
102,03
|
203 550 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
1 942
-3.7%
101,99
198 065 $US
|
1 942
-3.7%
|
101,99
|
198 065 $US
|
|
|
2025-11-21 |
2025-11-19 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
24 186
-31.8%
101,93
2 465 279 $US
|
24 186
-31.8%
|
101,93
|
2 465 279 $US
|
|
|
2025-11-19 |
2025-11-19 |
PrS
Vente proposée
|
Officer
Dirigeant
|
30 000
101,95
3 058 452 $US
|
30 000
|
101,95
|
3 058 452 $US
|
|
|
2025-09-05 |
2025-09-03 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
200
-0.6%
91,59
18 318 $US
|
200
-0.6%
|
91,59
|
18 318 $US
|
|
|
2025-09-05 |
2025-09-03 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
8 405
-19.0%
91,58
769 730 $US
|
8 405
-19.0%
|
91,58
|
769 730 $US
|
|
|
2025-09-03 |
2025-09-03 |
PrS
Vente proposée
|
Officer
Dirigeant
|
8 605
91,58
788 049 $US
|
8 605
|
91,58
|
788 049 $US
|
|
|
2025-08-25 |
2025-08-25 |
A
Achat
|
Administrateur non-exécutif
|
2 500
+100.0%
92,37
230 925 $US
|
2 500
+100.0%
|
92,37
|
230 925 $US
|
|
|
2025-08-25 |
2025-08-22 |
A
Achat
|
Administrateur non-exécutif
|
2 500
+inf%
92,73
231 825 $US
|
2 500
+inf%
|
92,73
|
231 825 $US
|
|
|
2025-06-06 |
2025-06-06 |
PrS
Vente proposée
|
Officer
Dirigeant
|
18 378
86,81
1 595 469 $US
|
18 378
|
86,81
|
1 595 469 $US
|
|
|
2025-01-27 |
2025-01-24 |
V
Vente
|
EVP & Pres Neuroscience
Dirigeant
|
12 437
-23.3%
90,00
1 119 330 $US
|
12 437
-23.3%
|
90,00
|
1 119 330 $US
|
|
|
2025-01-24 |
2025-01-24 |
PrS
Vente proposée
|
Officer
Dirigeant
|
12 437
90,00
1 119 330 $US
|
12 437
|
90,00
|
1 119 330 $US
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
EVP & Pres Neuroscience
Dirigeant
|
3 000
-6.9%
80,41
241 230 $US
|
3 000
-6.9%
|
80,41
|
241 230 $US
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
EVP & Pres Neuroscience
Dirigeant
|
6 850
-13.5%
80,41
550 808 $US
|
6 850
-13.5%
|
80,41
|
550 808 $US
|
|
|
2025-01-08 |
2025-01-08 |
PrS
Vente proposée
|
Officer
Dirigeant
|
9 850
80,41
792 038 $US
|
9 850
|
80,41
|
792 038 $US
|
|
|
2024-10-31 |
2024-10-31 |
PrS
Vente proposée
|
Former Director
Administrateur non-exécutif
|
30 000
89,73
2 691 794 $US
|
30 000
|
89,73
|
2 691 794 $US
|
|
|
2024-10-30 |
2024-10-30 |
PrS
Vente proposée
|
Former Director
Administrateur non-exécutif
|
15 000
90,58
1 358 740 $US
|
15 000
|
90,58
|
1 358 740 $US
|
|
|
2024-10-29 |
2024-10-29 |
PrS
Vente proposée
|
Former BOD
|
15 000
91,16
1 367 348 $US
|
15 000
|
91,16
|
1 367 348 $US
|
|
|
2024-10-24 |
2024-10-24 |
PrS
Vente proposée
|
Former Director
Administrateur non-exécutif
|
22 712
92,49
2 100 633 $US
|
22 712
|
92,49
|
2 100 633 $US
|
|
|
2024-10-23 |
2024-10-23 |
PrS
Vente proposée
|
Former Director
Administrateur non-exécutif
|
23 848
91,76
2 188 205 $US
|
23 848
|
91,76
|
2 188 205 $US
|
|
|
2024-10-18 |
2024-10-18 |
PrS
Vente proposée
|
Former BOD
|
48 825
91,74
4 479 310 $US
|
48 825
|
91,74
|
4 479 310 $US
|
|
|
2024-10-17 |
2024-10-17 |
PrS
Vente proposée
|
Former BOD
|
55 179
89,87
4 958 718 $US
|
55 179
|
89,87
|
4 958 718 $US
|
|
|
2024-08-26 |
2024-08-26 |
PrS
Vente proposée
|
Former Officer
Dirigeant
|
2 668
90,00
240 120 $US
|
2 668
|
90,00
|
240 120 $US
|
|
|
2024-06-11 |
2024-06-07 |
V
Vente
|
Chairman and CEO
Administrateur exécutif
|
1 594
-1.1%
83,82
133 609 $US
|
1 594
-1.1%
|
83,82
|
133 609 $US
|
|
|
2024-06-11 |
2024-06-07 |
V
Vente
|
Chairman and CEO
Administrateur exécutif
|
17 519
-10.8%
83,76
1 467 391 $US
|
17 519
-10.8%
|
83,76
|
1 467 391 $US
|
|
|
2024-06-07 |
2024-06-07 |
PrS
Vente proposée
|
Officer; Director
Administrateur exécutif
|
19 113
83,77
1 601 102 $US
|
19 113
|
83,77
|
1 601 102 $US
|
|
|
2024-04-09 |
2024-04-08 |
V
Vente
|
EVP & President, Surgical OU
Dirigeant
|
854
-3.0%
83,14
71 002 $US
|
854
-3.0%
|
83,14
|
71 002 $US
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
16 035
-24.9%
85,12
1 364 899 $US
|
16 035
-24.9%
|
85,12
|
1 364 899 $US
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
13 066
-16.9%
85,15
1 112 570 $US
|
13 066
-16.9%
|
85,15
|
1 112 570 $US
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
1 594
-2.0%
85,06
135 586 $US
|
1 594
-2.0%
|
85,06
|
135 586 $US
|
|
|
2024-02-21 |
2024-02-21 |
PrS
Vente proposée
|
Officer
Dirigeant
|
30 695
85,13
2 613 202 $US
|
30 695
|
85,13
|
2 613 202 $US
|
|
|
2023-12-20 |
2023-12-19 |
PlS
Vente planifiée
|
EVP & Pres Neuroscience
Dirigeant
|
4 997
-14.7%
82,17
410 603 $US
|
4 997
-14.7%
|
82,17
|
410 603 $US
|
|
|
2023-12-19 |
2023-12-19 |
PrS
Vente proposée
|
Officer
Dirigeant
|
4 997
82,17
410 603 $US
|
4 997
|
82,17
|
410 603 $US
|
|
|
2023-08-25 |
2023-08-23 |
V
Vente
|
EVP Global Ops & Supply Chain
Dirigeant
|
10 000
-17.6%
83,84
838 400 $US
|
10 000
-17.6%
|
83,84
|
838 400 $US
|
|
|
2023-08-23 |
2023-08-23 |
PrS
Vente proposée
|
Officer
Dirigeant
|
10 000
83,84
838 442 $US
|
10 000
|
83,84
|
838 442 $US
|
|
|
2023-08-16 |
2023-08-14 |
PlS
Vente planifiée
|
EVP & Pres Neuroscience
Dirigeant
|
1 000
-2.9%
83,38
83 380 $US
|
1 000
-2.9%
|
83,38
|
83 380 $US
|
|
|
2023-08-14 |
2023-08-14 |
PrS
Vente proposée
|
Officer
Dirigeant
|
1 000
83,38
83 380 $US
|
1 000
|
83,38
|
83 380 $US
|
|
|
2023-08-07 |
2023-08-04 |
PlS
Vente planifiée
|
EVP & President, Surgical OU
Dirigeant
|
1 352
-4.5%
84,11
113 717 $US
|
1 352
-4.5%
|
84,11
|
113 717 $US
|
|
|
2023-08-04 |
2023-08-04 |
PrS
Vente proposée
|
Officer
Dirigeant
|
1 352
84,11
113 717 $US
|
1 352
|
84,11
|
113 717 $US
|
|
|
2023-07-18 |
2023-07-14 |
PlS
Vente planifiée
|
EVP & Pres Neuroscience
Dirigeant
|
2 000
-7.7%
87,97
175 940 $US
|
2 000
-7.7%
|
87,97
|
175 940 $US
|
|
|
2023-07-14 |
2023-07-14 |
PrS
Vente proposée
|
Officer
Dirigeant
|
2 000
87,97
175 940 $US
|
2 000
|
87,97
|
175 940 $US
|
|
|
2023-07-12 |
2023-07-10 |
V
Vente
|
EVP and Pres. Global Regions
Dirigeant
|
3 706
-7.8%
86,58
320 865 $US
|
3 706
-7.8%
|
86,58
|
320 865 $US
|
|
|
2023-07-12 |
2023-07-10 |
V
Vente
|
EVP and Pres. Global Regions
Dirigeant
|
1 808
-4.0%
86,59
156 555 $US
|
1 808
-4.0%
|
86,59
|
156 555 $US
|
|
|
2023-07-10 |
2023-07-10 |
PrS
Vente proposée
|
Officer
Dirigeant
|
5 514
86,59
477 440 $US
|
5 514
|
86,59
|
477 440 $US
|
|
|
2022-12-16 |
2022-12-13 |
V
Vente
|
EVP & President Cardiovascular
Dirigeant
|
16 631
-31.5%
80,50
1 338 736 $US
|
16 631
-31.5%
|
80,50
|
1 338 736 $US
|
|
|
2022-10-17 |
2022-10-14 |
V
Vente
|
EVP and Pres. Global Regions
Dirigeant
|
2 404
-5.2%
81,54
196 015 $US
|
2 404
-5.2%
|
81,54
|
196 015 $US
|
|
|
2022-03-21 |
2022-03-18 |
PlS
Vente planifiée
|
EVP & Chief Financial Officer
Dirigeant
|
682
-1.9%
110,00
75 020 $US
|
682
-1.9%
|
110,00
|
75 020 $US
|
|
|
2022-03-14 |
2022-03-11 |
V
Vente
|
SVP, Chief HR Officer
Dirigeant
|
6 000
-17.4%
105,30
631 800 $US
|
6 000
-17.4%
|
105,30
|
631 800 $US
|
|
|
2021-12-17 |
2021-12-16 |
A
Achat
|
Administrateur non-exécutif
|
5 010
+4.8%
103,26
517 333 $US
|
5 010
+4.8%
|
103,26
|
517 333 $US
|
|
|
2021-12-07 |
2021-12-06 |
PlS
Vente planifiée
|
EVP & Chief Financial Officer
Dirigeant
|
682
-1.9%
110,00
75 020 $US
|
682
-1.9%
|
110,00
|
75 020 $US
|
|
|
2021-10-01 |
2021-09-30 |
PlS
Vente planifiée
|
SVP General Counsel & Corp Sec
Dirigeant
|
49 147
-50.2%
126,58
6 221 027 $US
|
49 147
-50.2%
|
126,58
|
6 221 027 $US
|
|
|
2021-08-26 |
2021-08-25 |
V
Vente
|
EVP & Pres Diabetes/Cardiovasc
Dirigeant
|
7 290
-17.9%
134,09
977 516 $US
|
7 290
-17.9%
|
134,09
|
977 516 $US
|
|
|
2021-08-26 |
2021-08-25 |
V
Vente
|
EVP & Pres Diabetes/Cardiovasc
Dirigeant
|
21 129
-38.8%
134,08
2 832 976 $US
|
21 129
-38.8%
|
134,08
|
2 832 976 $US
|
|
|
2021-08-04 |
2021-08-02 |
PlS
Vente planifiée
|
SVP General Counsel & Corp Sec
Dirigeant
|
4 000
-7.7%
131,52
526 080 $US
|
4 000
-7.7%
|
131,52
|
526 080 $US
|
|
|
2021-06-17 |
2021-06-15 |
PlS
Vente planifiée
|
EVP & Chief Financial Officer
Dirigeant
|
605
-0.7%
124,47
75 304 $US
|
605
-0.7%
|
124,47
|
75 304 $US
|
|
|
2021-06-02 |
2021-06-01 |
PlS
Vente planifiée
|
EVP & Pres Neuroscience
Dirigeant
|
2 473
-10.3%
128,07
316 717 $US
|
2 473
-10.3%
|
128,07
|
316 717 $US
|
|
|
2021-06-01 |
2021-05-28 |
PlS
Vente planifiée
|
EVP & President of Americas
Dirigeant
|
34 656
-44.9%
126,65
4 389 182 $US
|
34 656
-44.9%
|
126,65
|
4 389 182 $US
|
|
|
2021-04-07 |
2021-04-05 |
PlS
Vente planifiée
|
CEO
Administrateur exécutif
|
9 308
-10.2%
118,83
1 106 070 $US
|
9 308
-10.2%
|
118,83
|
1 106 070 $US
|
|
|
2021-04-07 |
2021-04-05 |
PlS
Vente planifiée
|
CEO
Administrateur exécutif
|
2 404
-2.9%
118,83
285 667 $US
|
2 404
-2.9%
|
118,83
|
285 667 $US
|
|
|
2021-03-16 |
2021-03-15 |
PlS
Vente planifiée
|
EVP & Chief Financial Officer
Dirigeant
|
632
-0.7%
119,12
75 284 $US
|
632
-0.7%
|
119,12
|
75 284 $US
|
|
|
2021-03-03 |
2021-03-02 |
V
Vente
|
EVP & President EMEA
Dirigeant
|
7 168
-14.1%
117,98
845 681 $US
|
7 168
-14.1%
|
117,98
|
845 681 $US
|
|
|
2020-12-30 |
2020-12-28 |
V
Vente
|
SVP, Chief HR Officer
Dirigeant
|
15 000
-30.5%
114,90
1 723 500 $US
|
15 000
-30.5%
|
114,90
|
1 723 500 $US
|
|